Physiological Study of the Human CYP3A Activity (PiSA)
Condition(s):Cytochrome P450 CYP3A Enzyme DeficiencyLast Updated:April 18, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Cytochrome P450 CYP3A Enzyme DeficiencyLast Updated:April 18, 2018Completed
Condition(s):Anovulation; Disorder Due Cytochrome P450 CYP2D6 Variant; Cytochrome P450 CYP3A Enzyme DeficiencyLast Updated:February 24, 2015Completed
Condition(s):Adverse Drug Events; Adverse Drug Reactions; Drug Interaction Potentiation; Drug Metabolism, Poor, CYP2D6-RELATED; Drug Metabolism, Poor, CYP2C19-RELATED; Cytochrome P450 Enzyme Deficiency; Cytochrome P450 CYP2D6 Enzyme Deficiency; Cytochrome P450 CYP2C9 Enzyme Deficiency; Cytochrome P450 CYP2C19 Enzyme Deficiency; Cytochrome P450 CYP3A Enzyme Deficiency; Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant; Poor Metabolizer Due to Cytochrome P450 CYP2C19 Variant; Poor Metabolizer Due to Cytochrome P450 CYP2D6 VariantLast Updated:March 1, 2017Completed
Condition(s):Adverse Drug Events; Adverse Drug Reactions; Drug Interaction Potentiation; Drug Metabolism, Poor, CYP2D6-RELATED; Drug Metabolism, Poor, CYP2C19-RELATED; Cytochrome P450 Enzyme Deficiency; Cytochrome P450 CYP2D6 Enzyme Deficiency; Cytochrome P450 CYP2C9 Enzyme Deficiency; Cytochrome P450 CYP2C19 Enzyme Deficiency; Cytochrome P450 CYP3A Enzyme Deficiency; Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant; Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant; Poor Metabolizer Due to Cytochrome P450 CYP2D6 VariantLast Updated:September 20, 2019Completed
Condition(s):Chronic Kidney Diseases; Deficiency, Vitamin DLast Updated:June 30, 2021Completed
Condition(s):Venous Thrombosis; Deep Vein ThrombosisLast Updated:November 18, 2015Completed
Condition(s):CCR5-tropic HIV-1 InfectionLast Updated:January 2, 2020Completed
Condition(s):Individuality; Narrative MedicineLast Updated:November 19, 2014Unknown status
Condition(s):Hematologic Malignancies; Nonmalignant Diseases; Immune Deficiency; Hemoglobinopathies; Genetic Inborn Errors of Metabolism; Fanconi Anemia; Thalassemia; Sickle Cell DiseaseLast Updated:September 21, 2023Completed
Condition(s):Cytochrome P450 CYP2D6 Enzyme Deficiency; Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant; Ultrarapid Metabolizer Due to Cytochrome P450 CYP2D6 Variant; Extensive Metabolizer Due to Cytochrome P450 CYP2D6 Variant; Cytochrome P450 CYP2C9 Enzyme Deficiency; Cytochrome P450 CYP2C19 Enzyme Deficiency; Drug Metabolism, Poor, CYP2D6-RELATED; Drug Metabolism, Poor, CYP2C19-RELATED; CYP2D6 PolymorphismLast Updated:February 23, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.